Trial Details
COMPLETEDBasic Information
| Clinical ID | c1101 |
|---|---|
| Identifier | NCT02914522 |
| Trial Title | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Filgotinib|DRUG: PTM filgotinib |
Participant Information
| Sponsor | Gilead Sciences |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2016-11-14 |
|---|---|
| Primary Completion Date | 2020-03-31 |
| Completion Date | 2020-03-31 |